Literature DB >> 12229881

Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia.

Jorg Basecke, Lukas Cepek, Christine Mannhalter, Jurgen Krauter, Stefanie Hildenhagen, Guenter Brittinger, Lorenz Trumper, Frank Griesinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12229881     DOI： 10.1182/blood-2002-06-1673

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.

Authors:  Ashley N Mays; Neil Osheroff; Yuanyuan Xiao; Joseph L Wiemels; Carolyn A Felix; Jo Ann W Byl; Kandeepan Saravanamuttu; Andrew Peniket; Robert Corser; Cherry Chang; Christine Hoyle; Anne N Parker; Syed K Hasan; Francesco Lo-Coco; Ellen Solomon; David Grimwade
Journal:  Blood       Date:  2009-11-02       Impact factor: 22.113

2.  The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.

Authors:  Naohiro Sekiguchi; Takashi Watanabe; Yukio Kobayashi; Chiho Inokuchi; Sung-Won Kim; Yukiko Yokota; Kazuki Tanimoto; Yoshihiro Matsuno; Kensei Tobinai
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 3.  Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Authors:  Kelly Faulk; Lia Gore; Todd Cooper
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

4.  Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals.

Authors:  Jianbo Song; Danielle Mercer; Xiaofeng Hu; Henry Liu; Marilyn M Li
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

Review 5.  RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

Authors:  James K Mangan; Nancy A Speck
Journal:  Crit Rev Oncog       Date:  2011

6.  Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.

Authors:  Shinobu Matsuura; Ming Yan; Miao-Chia Lo; Eun-Young Ahn; Stephanie Weng; David Dangoor; Mahan Matin; Tsunehito Higashi; Gen-Sheng Feng; Dong-Er Zhang
Journal:  Blood       Date:  2012-01-05       Impact factor: 22.113

Review 7.  Molecular biology of therapy-related leukaemias.

Authors:  Melanie Joannides; David Grimwade
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

8.  Monitoring AML1-ETO and CBFbeta-MYH11 transcripts in acute myeloid leukemia.

Authors:  John A Liu Yin; Lindsay Frost
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 9.  Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.

Authors:  Gerald B W Wertheim; Elizabeth Hexner; Adam Bagg
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

10.  Molecular pathogenesis of secondary acute promyelocytic leukemia.

Authors:  M Joannides; A N Mays; A R Mistry; S K Hasan; A Reiter; J L Wiemels; C A Felix; F Lo Coco; N Osheroff; E Solomon; D Grimwade
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.